First generation of real microbiome-based therapeutics
Microbiome therapeutics biotech mbiomics raises EUR 13 million in first closing of Series A round
28-Mar-2023 -
mbiomics GmbH, a pioneering microbiome biotech company developing the first generation of effective microbiome-based therapeutics announced the first closing of EUR13 million (US$ 15 million) of a series A financing round led by MIG Capital. High-Tech Gründerfonds and Bayern Kapital joined the ...
microbiota
Series A financing
therapeutics